Article: Migraine Sufferers Experience Complete Headache Response With ZOMIG(R) (zolmitriptan).

Data Reinforce Zolmitriptan Provides Patients

Powerful Migraine Relief Anytime During an Attack

BOSTON, June 11 /PRNewswire/ -- Forty-four percent of migraine sufferers who use ZOMIG Tablets experience complete headache response, according to data presented at the American Association for the Study of Headache (AASH) 41st Annual Scientific Meeting.(1)

Results of a retrospective chart review of records and patient diaries for treatment, response and adverse effects showed ZOMIG had the highest percentage of complete headache responders among studied triptans. ZOMIG also demonstrated good tolerability and low incidence of headache recurrence.(1) ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!